311 related articles for article (PubMed ID: 22457595)
1. Increased brain radioactivity by intranasal P-labeled siRNA dendriplexes within in situ-forming mucoadhesive gels.
Perez AP; Mundiña-Weilenmann C; Romero EL; Morilla MJ
Int J Nanomedicine; 2012; 7():1373-85. PubMed ID: 22457595
[TBL] [Abstract][Full Text] [Related]
2. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties.
Zaki NM; Awad GA; Mortada ND; Abd Elhady SS
Eur J Pharm Sci; 2007 Dec; 32(4-5):296-307. PubMed ID: 17920822
[TBL] [Abstract][Full Text] [Related]
3. In situ mucoadhesive-thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin.
Mura P; Mennini N; Nativi C; Richichi B
Eur J Pharm Biopharm; 2018 Jan; 122():54-61. PubMed ID: 29032194
[TBL] [Abstract][Full Text] [Related]
4. Formulation and characterization of intranasal mucoadhesive nanoparticulates and thermo-reversible gel of levodopa for brain delivery.
Sharma S; Lohan S; Murthy RS
Drug Dev Ind Pharm; 2014 Jul; 40(7):869-78. PubMed ID: 23600649
[TBL] [Abstract][Full Text] [Related]
5. Nasal in-situ gels for delivery of rasagiline mesylate: improvement in bioavailability and brain localization.
Ravi PR; Aditya N; Patil S; Cherian L
Drug Deliv; 2015; 22(7):903-10. PubMed ID: 24286183
[TBL] [Abstract][Full Text] [Related]
6. Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats.
Khan S; Patil K; Bobade N; Yeole P; Gaikwad R
J Drug Target; 2010 Apr; 18(3):223-34. PubMed ID: 20030503
[TBL] [Abstract][Full Text] [Related]
7. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery.
Hao J; Zhao J; Zhang S; Tong T; Zhuang Q; Jin K; Chen W; Tang H
Colloids Surf B Biointerfaces; 2016 Nov; 147():376-386. PubMed ID: 27566226
[TBL] [Abstract][Full Text] [Related]
8. Formulation, functional evaluation and ex vivo performance of thermoresponsive soluble gels - A platform for therapeutic delivery to mucosal sinus tissue.
Pandey P; Cabot PJ; Wallwork B; Panizza BJ; Parekh HS
Eur J Pharm Sci; 2017 Jan; 96():499-507. PubMed ID: 27771516
[TBL] [Abstract][Full Text] [Related]
9. A novel nasal almotriptan loaded solid lipid nanoparticles in mucoadhesive in situ gel formulation for brain targeting: Preparation, characterization and in vivo evaluation.
Youssef NAHA; Kassem AA; Farid RM; Ismail FA; El-Massik MAE; Boraie NA
Int J Pharm; 2018 Sep; 548(1):609-624. PubMed ID: 30033394
[TBL] [Abstract][Full Text] [Related]
10. Intranasal In Situ Gel of Apixaban-Loaded Nanoethosomes: Preparation, Optimization, and In Vivo Evaluation.
El-Shenawy AA; Mahmoud RA; Mahmoud EA; Mohamed MS
AAPS PharmSciTech; 2021 May; 22(4):147. PubMed ID: 33948767
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Blatta orientalis (Q) nasal gel formulation in milk aspiration induced eosinophilia.
Nimgulkar CC; Patil SD; Chauk DS
Pharm Dev Technol; 2009; 14(4):435-41. PubMed ID: 19552565
[TBL] [Abstract][Full Text] [Related]
12. Chlorpheniramine maleate containing chitosan-based nanoparticle-loaded thermosensitive in situ gel for management in allergic rhinitis.
Kumar M; Upadhayay P; Shankar R; Joshi M; Bhatt S; Malik A
Drug Deliv Transl Res; 2019 Dec; 9(6):1017-1026. PubMed ID: 31049842
[TBL] [Abstract][Full Text] [Related]
13. Development, characterization and application of in situ gel systems for intranasal delivery of tacrine.
Qian S; Wong YC; Zuo Z
Int J Pharm; 2014 Jul; 468(1-2):272-82. PubMed ID: 24709220
[TBL] [Abstract][Full Text] [Related]
14. Formulation and Evaluation of Thermoreversible In Situ Nasal Gels Containing Mometasone Furoate for Allergic Rhinitis.
Altuntaş E; Yener G
AAPS PharmSciTech; 2017 Oct; 18(7):2673-2682. PubMed ID: 28281209
[TBL] [Abstract][Full Text] [Related]
15. Formulation development and evaluation of nasal
Boraste SV; Patil SB
Drug Dev Ind Pharm; 2024 Jan; 50(1):11-22. PubMed ID: 38054848
[TBL] [Abstract][Full Text] [Related]
16. Development of novel bioadhesive granisetron hydrochloride spanlastic gel and insert for brain targeting and study their effects on rats.
Abdelmonem R; El Nabarawi M; Attia A
Drug Deliv; 2018 Nov; 25(1):70-77. PubMed ID: 29228824
[TBL] [Abstract][Full Text] [Related]
17. Preparation and
Alami-Milani M; Salatin S; Rayeni FS; Jelvehgari M
Ther Deliv; 2021 Jun; 12(6):461-475. PubMed ID: 34013779
[No Abstract] [Full Text] [Related]
18. Poloxamer/cyclodextrin/chitosan-based thermoreversible gel for intranasal delivery of fexofenadine hydrochloride.
Cho HJ; Balakrishnan P; Park EK; Song KW; Hong SS; Jang TY; Kim KS; Chung SJ; Shim CK; Kim DD
J Pharm Sci; 2011 Feb; 100(2):681-91. PubMed ID: 20803575
[TBL] [Abstract][Full Text] [Related]
19. Development of in situ gel for nasal delivery: design, optimization, in vitro and in vivo evaluation.
Galgatte UC; Kumbhar AB; Chaudhari PD
Drug Deliv; 2014 Feb; 21(1):62-73. PubMed ID: 24191774
[TBL] [Abstract][Full Text] [Related]
20. Intranasal delivery of ciprofloxacin to rats: A topical approach using a thermoreversible in situ gel.
Sousa J; Alves G; Oliveira P; Fortuna A; Falcão A
Eur J Pharm Sci; 2017 Jan; 97():30-37. PubMed ID: 27810560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
